Imaging changes after stereotactic radiosurgery of primary and secondary malignant brain tumors

Donald (Don) Ross, Howard M. Sandler, James M. Balter, James A. Hayman, Paul G. Archer, Donna L. Auer

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

After radiosurgery of malignant tumors, it can be difficult to discriminate between transient treatment effects, radiation necrosis, and tumor progression on post-treatment imaging. Misinterpretation of an enlarging lesion may lead to inappropriate treatment and contribute to disagreements about treatment efficacy. In an effort to clarify this problem, we reviewed our experience with interpreting post-radiosurgical imaging in patients with malignant primary and secondary brain tumors. We reviewed results of radiosurgery of 30 malignant gliomas and 35 metastatic brain tumors with minimum follow up of 1 year or until death. Of 30 gliomas, 73% were larger a mean of 13 weeks after radiosurgery. Of 35 metastatic tumors, 22% were larger a mean of 10 weeks after radiosurgery. Eleven had 18F-fluorodeoxyglucose-positron emission tomography (FDG-PET) of enlarging lesions. Eight showed increased activity with respect to brain; three decreased activity. Of the eight, six predicted incorrectly based upon the patients' subsequent courses (all alive, mean follow up of 27 months), and two correctly, with the patients dying from the imaged lesions 8 and 13 months later. Of the three with FDG uptake less than brain, one patient was alive with 32 weeks of follow up, and two patients died from the imaged lesion 13 and 21 months later. Radiographic enlargement after radiosurgery is common, especially for gliomas. Physicians caring for these patients should be aware of this phenomenon and be cautious in interpreting post-treatment images. MRI appearance may be useful for metastases. FDG-PET seems unreliable. Further evaluation of T1-201 and HMPAO SPECT or MRS is warranted.

Original languageEnglish (US)
Pages (from-to)175-181
Number of pages7
JournalJournal of Neuro-Oncology
Volume56
Issue number2
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Radiosurgery
Brain Neoplasms
Glioma
Positron-Emission Tomography
Neoplasms
Radiation Effects
Fluorodeoxyglucose F18
Brain
Therapeutics
Single-Photon Emission-Computed Tomography
Necrosis
Neoplasm Metastasis
Physicians

Keywords

  • Glioma
  • Magnetic resonance imaging
  • Metastasis to brain
  • Positron emission tomography
  • Single photon emission computed tomography
  • Stereotactic radiosurgery

ASJC Scopus subject areas

  • Clinical Neurology
  • Cancer Research
  • Oncology
  • Neuroscience(all)

Cite this

Imaging changes after stereotactic radiosurgery of primary and secondary malignant brain tumors. / Ross, Donald (Don); Sandler, Howard M.; Balter, James M.; Hayman, James A.; Archer, Paul G.; Auer, Donna L.

In: Journal of Neuro-Oncology, Vol. 56, No. 2, 2002, p. 175-181.

Research output: Contribution to journalArticle

Ross, Donald (Don) ; Sandler, Howard M. ; Balter, James M. ; Hayman, James A. ; Archer, Paul G. ; Auer, Donna L. / Imaging changes after stereotactic radiosurgery of primary and secondary malignant brain tumors. In: Journal of Neuro-Oncology. 2002 ; Vol. 56, No. 2. pp. 175-181.
@article{82f57ec5bd7b42cc834ed9e7ed395d0a,
title = "Imaging changes after stereotactic radiosurgery of primary and secondary malignant brain tumors",
abstract = "After radiosurgery of malignant tumors, it can be difficult to discriminate between transient treatment effects, radiation necrosis, and tumor progression on post-treatment imaging. Misinterpretation of an enlarging lesion may lead to inappropriate treatment and contribute to disagreements about treatment efficacy. In an effort to clarify this problem, we reviewed our experience with interpreting post-radiosurgical imaging in patients with malignant primary and secondary brain tumors. We reviewed results of radiosurgery of 30 malignant gliomas and 35 metastatic brain tumors with minimum follow up of 1 year or until death. Of 30 gliomas, 73{\%} were larger a mean of 13 weeks after radiosurgery. Of 35 metastatic tumors, 22{\%} were larger a mean of 10 weeks after radiosurgery. Eleven had 18F-fluorodeoxyglucose-positron emission tomography (FDG-PET) of enlarging lesions. Eight showed increased activity with respect to brain; three decreased activity. Of the eight, six predicted incorrectly based upon the patients' subsequent courses (all alive, mean follow up of 27 months), and two correctly, with the patients dying from the imaged lesions 8 and 13 months later. Of the three with FDG uptake less than brain, one patient was alive with 32 weeks of follow up, and two patients died from the imaged lesion 13 and 21 months later. Radiographic enlargement after radiosurgery is common, especially for gliomas. Physicians caring for these patients should be aware of this phenomenon and be cautious in interpreting post-treatment images. MRI appearance may be useful for metastases. FDG-PET seems unreliable. Further evaluation of T1-201 and HMPAO SPECT or MRS is warranted.",
keywords = "Glioma, Magnetic resonance imaging, Metastasis to brain, Positron emission tomography, Single photon emission computed tomography, Stereotactic radiosurgery",
author = "Ross, {Donald (Don)} and Sandler, {Howard M.} and Balter, {James M.} and Hayman, {James A.} and Archer, {Paul G.} and Auer, {Donna L.}",
year = "2002",
doi = "10.1023/A:1014571900854",
language = "English (US)",
volume = "56",
pages = "175--181",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Kluwer Academic Publishers",
number = "2",

}

TY - JOUR

T1 - Imaging changes after stereotactic radiosurgery of primary and secondary malignant brain tumors

AU - Ross, Donald (Don)

AU - Sandler, Howard M.

AU - Balter, James M.

AU - Hayman, James A.

AU - Archer, Paul G.

AU - Auer, Donna L.

PY - 2002

Y1 - 2002

N2 - After radiosurgery of malignant tumors, it can be difficult to discriminate between transient treatment effects, radiation necrosis, and tumor progression on post-treatment imaging. Misinterpretation of an enlarging lesion may lead to inappropriate treatment and contribute to disagreements about treatment efficacy. In an effort to clarify this problem, we reviewed our experience with interpreting post-radiosurgical imaging in patients with malignant primary and secondary brain tumors. We reviewed results of radiosurgery of 30 malignant gliomas and 35 metastatic brain tumors with minimum follow up of 1 year or until death. Of 30 gliomas, 73% were larger a mean of 13 weeks after radiosurgery. Of 35 metastatic tumors, 22% were larger a mean of 10 weeks after radiosurgery. Eleven had 18F-fluorodeoxyglucose-positron emission tomography (FDG-PET) of enlarging lesions. Eight showed increased activity with respect to brain; three decreased activity. Of the eight, six predicted incorrectly based upon the patients' subsequent courses (all alive, mean follow up of 27 months), and two correctly, with the patients dying from the imaged lesions 8 and 13 months later. Of the three with FDG uptake less than brain, one patient was alive with 32 weeks of follow up, and two patients died from the imaged lesion 13 and 21 months later. Radiographic enlargement after radiosurgery is common, especially for gliomas. Physicians caring for these patients should be aware of this phenomenon and be cautious in interpreting post-treatment images. MRI appearance may be useful for metastases. FDG-PET seems unreliable. Further evaluation of T1-201 and HMPAO SPECT or MRS is warranted.

AB - After radiosurgery of malignant tumors, it can be difficult to discriminate between transient treatment effects, radiation necrosis, and tumor progression on post-treatment imaging. Misinterpretation of an enlarging lesion may lead to inappropriate treatment and contribute to disagreements about treatment efficacy. In an effort to clarify this problem, we reviewed our experience with interpreting post-radiosurgical imaging in patients with malignant primary and secondary brain tumors. We reviewed results of radiosurgery of 30 malignant gliomas and 35 metastatic brain tumors with minimum follow up of 1 year or until death. Of 30 gliomas, 73% were larger a mean of 13 weeks after radiosurgery. Of 35 metastatic tumors, 22% were larger a mean of 10 weeks after radiosurgery. Eleven had 18F-fluorodeoxyglucose-positron emission tomography (FDG-PET) of enlarging lesions. Eight showed increased activity with respect to brain; three decreased activity. Of the eight, six predicted incorrectly based upon the patients' subsequent courses (all alive, mean follow up of 27 months), and two correctly, with the patients dying from the imaged lesions 8 and 13 months later. Of the three with FDG uptake less than brain, one patient was alive with 32 weeks of follow up, and two patients died from the imaged lesion 13 and 21 months later. Radiographic enlargement after radiosurgery is common, especially for gliomas. Physicians caring for these patients should be aware of this phenomenon and be cautious in interpreting post-treatment images. MRI appearance may be useful for metastases. FDG-PET seems unreliable. Further evaluation of T1-201 and HMPAO SPECT or MRS is warranted.

KW - Glioma

KW - Magnetic resonance imaging

KW - Metastasis to brain

KW - Positron emission tomography

KW - Single photon emission computed tomography

KW - Stereotactic radiosurgery

UR - http://www.scopus.com/inward/record.url?scp=0036207546&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036207546&partnerID=8YFLogxK

U2 - 10.1023/A:1014571900854

DO - 10.1023/A:1014571900854

M3 - Article

C2 - 11995819

AN - SCOPUS:0036207546

VL - 56

SP - 175

EP - 181

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

IS - 2

ER -